
Investors should target the "picks and shovels" of the booming U.S. fertility industry, specifically focusing on IVF clinics, genetic testing labs, and sperm/egg banks that benefit from high-margin international demand. Intuit (INTU) is a high-conviction play in the software space as it moves up-market with its new AI-native Enterprise Suite to capture larger corporate contracts. For long-term exposure to the pro-natalist tech trend, monitor leaders in genomic medicine and CRISPR technology, which are positioned to serve the ultra-wealthy's growing interest in genetic engineering. Be cautious of Duoyi Network and similar firms led by controversial figures, as significant reputational and legal risks regarding surrogacy and corporate culture could impact valuations. Given the lack of federal oversight in the U.S. fertility market, prioritize diversified healthcare providers to hedge against potential future regulatory crackdowns.
The U.S. has become a global hub for the fertility industry, often referred to as the "NBA of the basketball field" due to its superior physicians, lab technicians, and technology. The industry is currently a multi-billion dollar sector driven by international demand.
Shu Bo is a prominent Chinese tech entrepreneur and the founder of Duoyi Network, a company that develops fantasy multiplayer video games. He is highlighted as a primary driver of the "mega-family" trend.
The transcript includes a promotional segment for the Intuit Enterprise Suite, a new AI-native ERP (Enterprise Resource Planning) solution.
The podcast identifies a growing trend among tech billionaires (specifically mentioning Elon Musk and Shu Bo) who are focused on high-volume procreation and genetic engineering.

By The Wall Street Journal & Spotify Studios
The most important stories about money, business and power. Hosted by Ryan Knutson and Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal. Get show merch here: https://wsjshop.com/collections/clothing